SONAR: A high-throughput pipeline for inferring antibody ontogenies from longitudinal sequencing of B cell transcripts

Frontiers in Immunology

Volumn 7, Issue SEP, 2016, Pages

  Schramm, Chaim A ^a,b   Sheng, Zizhang ^a   Zhang, Zhenhai ^a,c   Mascola, John R ^b   Kwong, Peter D ^a,b   Shapiro, Lawrence ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Antibody lineage; Antibody maturation; Antibody repertoire; B cell ontogeny; Longitudinal analysis; Next generation sequencing

Indexed keywords

ALGORITHM; ARTICLE; B LYMPHOCYTE; COMPUTER; DATA ANALYSIS SOFTWARE; GENE SEQUENCE; NEXT GENERATION SEQUENCING; PHYLOGENETIC TREE; PHYLOGENY; SCORING SYSTEM; SOFTWARE FOR THE ONTOGENIC ANALYSIS OF ANTIBODY REPERTOIRES;

EID: 84992060907     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00372     Document Type: Article

References (57)

1. Murphy K, Travers P, Walport M, Janeway C. Janeway's Immunobiology. New York: Garland Science (2012).
2. Sheng Z, Schramm CA, Connors M, Morris L, Mascola JR, Kwong PD, et al. Effects of Darwinian selection and mutability on rate of broadly neutralizing antibody evolution during HIV-1 infection. PLoS Comput Biol (2016) 12(5):e1004940. doi: 10.1371/journal.pcbi.1004940
3. Vollmers C, Sit RV, Weinstein JA, Dekker CL, Quake SR. Genetic measurement of memory B-cell recall using antibody repertoire sequencing. Proc Natl Acad Sci U S A (2013) 110(33):13463-8. doi:10.1073/pnas.1312146110
4. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol (2010) 17(7):1055-65. doi:10.1128/CVI.00131-10
5. Buss NA, Henderson SJ, McFarlane M, Shenton JM, de Haan L. Monoclonal antibody therapeutics: history and future. Curr Opin Pharmacol (2012) 12(5):615-22. doi:10.1016/j.coph.2012.08.001
6. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol (2001) 1(2):147-53. doi:10.1038/35100573
7. Cheah CY, Fowler NH, Wang ML. Breakthrough therapies in B-cell non-Hodgkin lymphoma. Ann Oncol (2016) 27(5):778-87. doi:10.1093/annonc/mdw029
8. Young RM, Shaffer AL III, Phelan JD, Staudt LM. B-cell receptor signaling in diffuse large B-cell lymphoma. Semin Hematol (2015) 52(2):77-85. doi:10.1053/j.seminhematol.2015.01.008
9. Gorman J, Soto C, Yang MM, Davenport TM, Guttman M, Bailer RT, et al. Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design. Nat Struct Mol Biol (2016) 23(1):81-90. doi:10.1038/nsmb.3144
10. Bonsignori M, Zhou T, Sheng Z, Chen L, Gao F, Joyce MG, et al. Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody. Cell (2016) 165(2):449-63. doi:10.1016/j.cell.2016.02.022
11. Doria-Rose NA, Schramm CA, Gorman J, Moore PL, Bhiman JN, DeKosky BJ, et al. Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies. Nature (2014) 509(7498):55-62. doi:10.1038/nature13036
12. Wu X, Zhang Z, Schramm CA, Joyce MG, Kwon YD, Zhou T, et al. Maturation and diversity of the VRC01-antibody lineage over 15 years of chronic HIV-1 infection. Cell (2015) 161(3):470-85. doi:10.1016/j.cell.2015.03.004
13. Rudicell RS, Kwon YD, Ko SY, Pegu A, Louder MK, Georgiev IS, et al. Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo. J Virol (2014) 88(21):12669-82. doi:10.1128/JVI.02213-14
14. Ledgerwood JE, Coates EE, Yamshchikov G, Saunders JG, Holman L, Enama ME, et al. Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults. Clin Exp Immunol (2015) 182(3):289-301. doi:10.1111/cei.12692
15. Kwon YD, Georgiev IS, Ofek G, Zhang B, Asokan M, Bailer RT, et al. Optimization of the solubility of HIV-1-neutralizing antibody 10E8 through somatic variation and structure-based design. J Virol (2016) 90(13):5899-914. doi:10.1128/JVI.03246-15
16. Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, Sahaf B, et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci Transl Med (2009) 1(12):12ra23. doi:10.1126/scitranslmed.3000540
17. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol (2008) 26(10):1135-45. doi:10.1038/nbt1486
18. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet (2010) 11(1):31-46. doi:10.1038/nrg2626
19. Six A, Mariotti-Ferrandiz ME, Chaara W, Magadan S, Pham HP, Lefranc MP, et al. The past, present, and future of immune repertoire biology-the rise of next-generation repertoire analysis. Front Immunol (2013) 4:413. doi:10.3389/fimmu.2013.00413
20. Lefranc MP, Giudicelli V, Duroux P, Jabado-Michaloud J, Folch G, Aouinti S, et al. IMGT(R), the international ImMunoGeneTics information system(R) 25 years on. Nucleic Acids Res (2015) 43(Database issue):D413-22. doi:10.1093/nar/gku1056
21. Souto-Carneiro MM, Longo NS, Russ DE, Sun HW, Lipsky PE. Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J Immunol (2004) 172(11):6790-802. doi:10.4049/jimmunol.172.11.6790
22. Russ DE, Ho KY, Longo NS. HTJoinSolver: human immunoglobulin VDJ partitioning using approximate dynamic programming constrained by conserved motifs. BMC Bioinformatics (2015) 16:170. doi:10.1186/s12859-015-0589-x
23. Ye J, Ma N, Madden TL, Ostell JM. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res (2013) 41(Web Server issue):W34-40. doi:10.1093/nar/gkt382
24. Paciello G, Acquaviva A, Pighi C, Ferrarini A, Macii E, Zamo A, et al. VDJSeq-solver: in silico V(D)J recombination detection tool. PLoS One (2015) 10(3):e0118192. doi:10.1371/journal.pone.0118192
25. Cortina-Ceballos B, Godoy-Lozano EE, Samano-Sanchez H, Aguilar-Salgado A, Velasco-Herrera Mdel C, Vargas-Chavez C, et al. Reconstructing and mining the B cell repertoire with immune diversity. MAbs (2015) 7(3):516-24. doi:10.1080/19420862.2015.1026502
26. Zhang W, Du Y, Su Z, Wang C, Zeng X, Zhang R, et al. IMonitor: a robust pipeline for TCR and BCR repertoire analysis. Genetics (2015) 201(2):459-72. doi:10.1534/genetics.115.176735
27. Kepler TB. Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors. F1000Res (2013) 2:103. doi:10.12688/f1000research.2-103.v1
28. Kepler TB, Munshaw S, Wiehe K, Zhang R, Yu JS, Woods CW, et al. Reconstructing a B-cell clonal lineage. II. Mutation, selection, and affinity maturation. Front Immunol (2014) 5:170. doi:10.3389/fimmu.2014.00170
29. Ralph DK, Matsen FA. Consistency of VDJ rearrangement and substitution parameters enables accurate B cell receptor sequence annotation. PLoS Comput Biol (2016) 12(1):e1004409. doi:10.1371/journal.pcbi.1004409
30. Jackson KJ, Liu Y, Roskin KM, Glanville J, Hoh RA, Seo K, et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe (2014) 16(1):105-14. doi:10.1016/j.chom.2014.05.013
31. Jiang N, He J, Weinstein JA, Penland L, Sasaki S, He XS, et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med (2013) 5(171):171ra19. doi:10.1126/scitranslmed.3004794
32. Laserson U, Vigneault F, Gadala-Maria D, Yaari G, Uduman M, Vander Heiden JA, et al. High-resolution antibody dynamics of vaccine-induced immune responses. Proc Natl Acad Sci U S A (2014) 111(13):4928-33. doi:10.1073/pnas.1323862111
33. Hershberg U, Luning Prak ET. The analysis of clonal expansions in normal and autoimmune B cell repertoires. Philos Trans R Soc Lond B Biol Sci (2015) 370(1676):239. doi:10.1098/rstb.2014.0239
34. Briney B, Le K, Zhu J, Burton DR. Clonify: unseeded antibody lineage assignment from next-generation sequencing data. Sci Rep (2016) 6:23901. doi:10.1038/srep23901
35. Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science (2011) 333(6049):1593-602. doi:10.1126/science.1207532
36. Zhu J, O'Dell S, Ofek G, Pancera M, Wu X, Zhang B, et al. Somatic populations of PGT135-137 HIV-1-neutralizing antibodies identified by 454 pyrosequencing and bioinformatics. Front Microbiol (2012) 3:315. doi:10.3389/fmicb.2012.00315
37. Barak M, Zuckerman NS, Edelman H, Unger R, Mehr R. IgTree: creating immunoglobulin variable region gene lineage trees. J Immunol Methods (2008) 338(1-2):67-74. doi:10.1016/j.jim.2008.06.006
38. Lees WD, Shepherd AJ. Utilities for high-throughput analysis of B-cell clonal lineages. J Immunol Res (2015) 2015:323506. doi:10.1155/2015/323506
39. Bhiman JN, Anthony C, Doria-Rose NA, Karimanzira O, Schramm CA, Khoza T, et al. Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies. Nat Med (2015) 21(11):1332-6. doi:10.1038/nm.3963
40. Liao HX, Lynch R, Zhou T, Gao F, Alam SM, Boyd SD, et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature (2013) 496(7446):469-76. doi:10.1038/nature12053
41. Doria-Rose NA, Bhiman JN, Roark RS, Schramm CA, Gorman J, Chuang GY, et al. New member of the V1V2-directed CAP256-VRC26 lineage that shows increased breadth and exceptional potency. J Virol (2016) 90(1):76-91. doi:10.1128/JVI.01791-15
42. Cock PJ, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, et al. BioPython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics (2009) 25(11):1422-3. doi:10.1093/bioinformatics/btp163
43. Stajich JE, Block D, Boulez K, Brenner SE, Chervitz SA, Dagdigian C, et al. The BioPerl toolkit: Perl modules for the life sciences. Genome Res (2002) 12(10):1611-8. doi:10.1101/gr.361602
44. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC Bioinformatics (2009) 10:421. doi:10.1186/1471-2105-10-421
45. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics (2010) 26(19):2460-1. doi:10.1093/bioinformatics/btq461
46. Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res (2004) 32(5):1792-7. doi:10.1093/nar/gkh340
47. Felsenstein J, Churchill GA. A hidden Markov model approach to variation among sites in rate of evolution. Mol Biol Evol (1996) 13(1):93-104. doi:10.1093/oxfordjournals.molbev.a025575
48. Bouckaert R, Heled J, Kuhnert D, Vaughan T, Wu CH, Xie D, et al. BEAST 2: a software platform for Bayesian evolutionary analysis. PLoS Comput Biol (2014) 10(4):e1003537. doi:10.1371/journal.pcbi.1003537
49. Huerta-Cepas J, Dopazo J, Gabaldon T. ETE: a Python environment for tree exploration. BMC Bioinformatics (2010) 11:24. doi:10.1186/1471-2105-11-24
50. Scheepers C, Shrestha RK, Lambson BE, Jackson KJ, Wright IA, Naicker D, et al. Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire. J Immunol (2015) 194(9):4371-8. doi:10.4049/jimmunol.1500118
51. Zhu J, Ofek G, Yang Y, Zhang B, Louder MK, Lu G, et al. Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains. Proc Natl Acad Sci U S A (2013) 110(16):6470-5. doi:10.1073/pnas.1219320110
52. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol (2011) 7:539. doi:10.1038/msb.2011.75
53. Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol (2013) 30(4):772-80. doi:10.1093/molbev/mst010
54. Zhu J, Wu X, Zhang B, McKee K, O'Dell S, Soto C, et al. De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts. Proc Natl Acad Sci U S A (2013) 110(43):E4088-97. doi:10.1073/pnas.1306262110
55. Georgiou G, Ippolito GC, Beausang J, Busse CE, Wardemann H, Quake SR. The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat Biotechnol (2014) 32(2):158-68. doi:10.1038/nbt.2782
56. Yaari G, Kleinstein SH. Practical guidelines for B-cell receptor repertoire sequencing analysis. Genome Med (2015) 7(1):121. doi:10.1186/s13073-015-0243-2
57. Jardine JG, Kulp DW, Havenar-Daughton C, Sarkar A, Briney B, Sok D, et al. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science (2016) 351(6280):1458-63. doi:10.1126/science.aad9195